Health
Study shows benefits of early anticlotting therapy in moderate COVID-19: International RAPID Trial could contribute to clinical practice – Science Daily
New research shows that administering a full dose of a standard blood thinner early to moderately ill hospitalized patients with…

COVID-19 is marked by heightened inflammation and abnormal clotting in the blood vessels, particularly in the lungs, and is believed to contribute to progression to severe disease and death. New trial results show that administering a full dose of a standard…
Continue Reading
-
Business19 hours ago
Why is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
Noosa News18 hours ago
‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
Noosa News15 hours ago
Tips to improve engagement – Proctor
-
Noosa News15 hours ago
Police appeal for information over suspected link in torture and murder cases